A comprehensive view of Metabolic Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Flagship Pioneering and Metaphore Biotechnologies partner with Novo Nordisk in a US$600.0M deal to develop two obesity treatments; the collaboration will leverage Metaphore's machine learning technology MIMICTM platform for drug discovery and development
Published: May 09, 2024 by PR Newswire
Eli Lilly and Company Files Argentine Patent Application for Dual Amylin and Calcitonin Receptor Agonists and Uses Thereof
Published: May 08, 2024 by Pharmaceutical Patent News
United States Patent for Tricyclic AKR1C3 Dependent KARS Inhibitors Issued to Novartis
Published: May 08, 2024 by Pharmaceutical Patent News
Eli Lilly and Company Files Australian Patent Application for Methods of Using a GIP/GLP1 Co-Agonist for Therapy
Published: May 08, 2024 by Pharmaceutical Patent News
Australian Patent Office Publishes Eli Lilly and Company's Patent Application for GIP/GLP1 Agonist Compositions
Published: May 08, 2024 by Pharmaceutical Patent News

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count